Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures

Overview of attention for article published in Antimicrobial Agents and Chemotherapy, January 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 1 news outlet

twitter: 7 X users

Readers on

mendeley: 50 Mendeley

So far, Altmetric has seen 11 X posts from 7 X users, with an upper bound of 17,496 followers.

Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures. https://t.co/CyDyhoDkA3

Scientists compare the therapeutic potential of ALX-0171 and palivizumab against #respiratory syncytial virus clinical isolate infection. https://t.co/RNDh73RnNY

RT @UltanPower: Really excited to share our new publication about using our WD-PBEC/RSV infection model to study RSV antivirals. Check it o…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.